ПЕРВИЧНЫЙ ГИПЕРПАРАТИРЕОЗ (обзор литературы)
https://doi.org/10.51523/2708-6011.2013-10-4-5
Аннотация
Первичный гиперпаратиреоз является распространенным эндокринологическим заболеванием у взрослых, типичным проявлением которого является бессимптомная гиперкальциемия. Первичный гиперпаратиреоз проявляется клинически у более молодых пациентов, у которых можно обнаружить признаки гиперкальциемии, осложнения со стороны опорно-двигательного аппарата и (или) нефролитиаз. В большинстве случаев первичный гиперпаратиреоз возникает вследствие солитарной доброкачественной аденомы паращитовидных желез, редко - множественных аденом. Вовлечение всех четырех паращитовидных желез, так называемая паратиреоидная гиперплазия, встречается у 10 % пациентов. Карцинома паращитовидных желез является редким заболеванием (распространенность менее 1 %). Основным методом лечения взрослых пациентов с первичным гиперпаратиреозом является хирургический, за исключением случаев, ассоциированных с наследственной гипокальциурической гиперкальциемией.
Об авторе
А. Д. Борсук
Республиканский научно-практический центр радиационной медицины и экологии человека, г. Гомель
Беларусь
Беларусь
Список литературы
1. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century / J. P. Bilezikian [et al.] // J. Bone Miner. Res. - 2002. - Vol. 17, № 2. - P. 2-11.
2. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease / R. A. Wermers [et al.] // J. Bone Miner. Res. - 2006. - Vol. 21, № 1. - P. 171-177.
3. Melton, L. J. The rise and fall of primary hyperparathyroidism: a population based study in Rochester, Minnesota, 1965-1992 / L. J. Melton // Ann. Int. Med. - 1997. - Vol. 126, № 6. - P. 433-440.
4. The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register / A. D. Morris [et al.] // Br. Med. J. - 1997. - Vol. 315. - P. 524-528.
5. Mortality and vascular outcomes in patients treated for thyroid dysfunction / R. W. Flynn [et al.] // J. Clin. Endocrinol. Metab. - 2006. - Vol. 91. - P. 2159-2164.
6. Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK / N. Yu [et al.] // J. Clin. Endocrin. - 2009. - Vol. 71. - P. 485-493.
7. Epidemiology of Primary Hyperparathyroidism in Europe - report commissioned by Amgen / The Mattson Jack Group // Ref Type: Report. - 2003.
8. Primary hyperparathyroidism. An underdiagnosed disease in Denmark / M. Blichert-Toft [et al.] // Ugeskr. Laeger. - 1993. - Vol. 155. - P. 765-769.
9. Kaplan, E. L. Primary hyperparathyroidism in the 1990s. Choice of surgical procedures for this disease / E. L. Kaplan, T. Yashiro, G. Salti // Ann. Surg. - 1992. - Vol. 215, № 4. - P. 300-317.
10. Khan, A. Primary hyperparathyroidism: pathophysiology and impact on bone / A. Khan, J. P. Bilezikian // Canad. Med. Assoc. Jorn. - 2000. - Vol. 163, № 2. - P. 184-187.
11. Clinical studies of multiple endocrine neoplasia type 1 (MENI) / D. Trump [et al.] // Q. J. Med. - 1996. - Vol. 89. - P. 653-669.
12. Beers, M. H. The Merck manual of diagnosis and therapy / M. H. Beers, R. Berkow // 17th ed. West Point, PA: Merck & Co Inc. - 1999.
13. Guidelines for diagnosis and therapy of MEN type 1 and type 2 / M. L. Brandi [et al.] // J. Clin. Endocrinol. Metab. - 2001. - Vol. 86. - P. 5658-5681.
14. Long-term follow-up after parathyroidectomy for radiation-induced hyperparathyroidism / G. Ippolito [et al.] // Surgery. - 2007. - Vol. 142, № 6. - P. 819-822.
15. Dose-response relationships for radiation-induced hyperparathyroidism / A. B. Schneider [et al.] // J. Clin. Endocrinol. Metab. - 1995. - Vol. 80. - P. 254-257.
16. The American Association of clinical endocrinologists and The American Association of endocrine surgeons. Position statement on the diagnosis and management of primary hyperparathyroidism. Endocrine Practice. - 2005. - Vol. 11. - P. 49-54.
17. Burney, R. E. Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels / R. E. Burney, K. R. Jones, B. Christy // Surgery. - 1999. - Vol. 125. - P. 608-614.
18. Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey / G. B. Talpos [et al.] // Surgery. - 2000. - Vol. 128. - P. 1013-1020.
19. Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study / A. K. Chan [et al.] // Ann. Surg. - 1995. - Vol. 222. - P. 402-414.
20. Diagnosis and management of asymptomatic hyperparathyroidism: safety, efficacy, and deficiencies in our knowledge / O. H. Clark [et al.] // J. Bone Miner. Res. - 1991. - Vol. 6, № 2. - P. 135-142.
21. Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up / T. Stefenelli [et al.] // J. Clin. Endocrinol. Metab. - 1997. - Vol. 82, № 1. - P. 106-112.
22. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial / E. Ambrogini [et al.] // Journal of Clinical Endocrinology & Metabolism. - 2007. - Vol. 92, № 8. - P. 3114-3121.
23. Bess, M. A. Hyperparathyroidism and pancreatitis. Chance or a causal association? / M. A. Bess, A. J. Edis, J. A. van Heerden // Journal of the American Medical Associations. - 1980. - Vol. 243. - P. 246-247.
24. Systematic Review of Primary Hyperparathyroidism in India: The Past, Present, and the Future Trends / P. V. Pradeep [et al.] // International Journal of Endocrinology. - 2011. - Vol. 2011. ID 921814, 7 pages.
25. Primary hyperparathyroidism in north India: a description of 52 cases / A. Bhansali [et al.] // Annals of Saudi Medicine. - 2005. - Vol. 25, № 1. - P. 29-35.
26. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years / M. R. Rubin [et al.] // J. Clin. Endocrinol. Metab. - 2008. - Vol. 93. - P. 3462-3470.
27. Makras, P. Medical treatment of hypercalcaemia / P. Makras, S. E. Papapoulos // Hormones. - 2009. - Vol. 8, № 2. - P. 83-95.
28. Gooding, A. W. Use of color Doppler imaging in the distinction between thyroid and parathyroid lesions / A. W. Gooding, O. H. Clark // Am. J. Surg. - 1992. - Vol. 164. - P. 51-56.
29. Johnson, N. A. Parathyroid imaging: Technique and role in the preoperative evaluation of primary hyperparathyroidism / N. A. Johnson, M. E. Tublin, J. B. Ogilvie // AJR. - 2007. - Vol. 188. - P. 1706-1715.
30. Dimashkieh, H. Ultrasound guided fine needle aspiration biopsy of parathyroid glands and lesions / H. Dimashkieh, S. Krishnamurthy // Cytojournal. - 2006. - Vol. 3. - P. 6.
31. Черенько, С. М. Первичный гиперпаратиреоз: основы патогенеза, диагностики и хирургического лечения / С. М. Черенько. - Киев, 2011. - C. 148.
32. Tcm sestamibi - a new agent for parathyroid imaging / A. J. Coakley [et al.] // Nucl. Med. Commun. - 1989. - Vol. 10. - P. 791-794.
33. Randolph, G. W. Surgery of the thyroid and parathyroid glands / G. W. Randolph. - Philadelphia: Elsevier Science (USA), 2003. - P. 620.
34. The impact of Sestamibi scanning on the outcome of parathyroid surgery / J. Allendorf [et al.] // J. Clin. Endocrinol. Metab. - 2003. - Vol. 88. - P. 3015-3018.
35. Advantages of combined techneticum-99m-sestamibi scintigraphy and high-resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism / F. Lumachi [et al.] // European Journal of Endocrinology. - 2000. - Vol. 143. - P. 755-760.
36. Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma / M. Haciyanli [et al.] // J. Am. Coll. Surg. - 2003. - Vol. 197. - P. 739-746.
37. Role of pre-operative imaging using (99m)Tc-MIBI and neck ultrasound in patients with secondary hyperparathyroidism who are candidates for subtotal parathyroidectomy / D. Fuster [et al.] // Eur. J. Nucl. Med. Mol. Imaging. - 2006. - Vol. 33. - P. 467-473.
38. Parathyroid glands: combination of sestamibi-(99m)Tc scintigraphy and ultrasonography for demonstration of hyperplasic parathyroid glands / E. T. Kasai [et al.] // Rev. Esp. Med. Nucl. - 2008. -Vol. 27. - P. 8-12.
39. Technetium-99m sestamibi scintigraphy and helical CT together in patients with primary hyperparathyroidism: a prospective clinical study / F. Lumachi [et al.] // BJR. - 2004. - Vol. 77. - P. 100-103.
40. Mihai, R. Imaging for primary hyperparathyroidism - an evidence-based analysis / R. Mihai, D. Simon, P. Hellman // Langenbeck’s Arch. Surg. - 2009. - Vol. 394. - P. 765-784.
41. Osamura, R. Y. Current practices in performing frozen sections for thyroid and parathyroid surgery / R. Y. Osamura, J. L. Hunt // Virchow Arch. - 2008. - Vol. 453. - P. 443-440.
42. Validation of a method to replace frozen section during parathyroid exploration by using the rapid parathyroid hormone assay on parathyroid aspirates / R. K. Chan [et al.] // Arch. Surg. - 2005. - Vol. 140. - P. 371-373.
43. Hedback, G. Death risk factor analysis in primary hyperparathyroidism / G. Hedback, A. Oden // Eur. J. Clin. Inv. - 1998. - Vol. 28. - P. 1011-1018.
44. Davies, M. Management of primary hyperparathyroidism / M. Davies, W. D. Fraser, D. J. Hosking // Clinical Endocrinology. - 2002. - Vol. 57. - P. 145-155.
Рецензия
Для цитирования:
Борсук А.Д. ПЕРВИЧНЫЙ ГИПЕРПАРАТИРЕОЗ (обзор литературы). Проблемы здоровья и экологии. 2013;(4):33-40. https://doi.org/10.51523/2708-6011.2013-10-4-5
For citation:
Borsuk A.D. PRIMARY HYPERPARATHYROIDISM (literature review). Health and Ecology Issues. 2013;(4):33-40. (In Russ.) https://doi.org/10.51523/2708-6011.2013-10-4-5
Просмотров: 304
Послать статью по эл. почте 